Location History:
- Williamstown, AU (2013 - 2017)
- Ascot Vale, AU (2015 - 2018)
Company Filing History:
Years Active: 2013-2024
Title: Pantelis Poumbourios: Innovator in Hepatitis C Research
Introduction
Pantelis Poumbourios is a distinguished inventor based in Ascot Vale, Australia. He has made significant contributions to the field of medical research, particularly in the development of vaccines and treatments for hepatitis C. With a total of 5 patents to his name, his work has had a profound impact on public health.
Latest Patents
Among his latest patents is a method for preparing multimeric forms of the hepatitis C virus (HCV) envelope glycoprotein 2 (HCV E2). This innovative method involves contacting a lower order antigen with a reducing agent to facilitate the assembly of higher order antigens. The process ensures that at least 10% of the lower order antigen is converted into a higher order antigen, which displays reduced binding to non-neutralizing antibodies while retaining binding to neutralizing antibodies. Additionally, he has developed a vaccine composition that combines the assembled higher order antigen with a pharmaceutically acceptable diluent, carrier, or adjuvant. His work also includes compositions that induce an HCV immune response, showcasing his commitment to advancing medical science.
Career Highlights
Pantelis Poumbourios is affiliated with the Macfarlane Burnet Institute for Medical Research and Public Health Limited. His career is marked by a dedication to research that addresses critical health challenges, particularly in the realm of infectious diseases. His innovative approaches have positioned him as a key figure in the scientific community.
Collaborations
He has collaborated with notable colleagues such as Heidi Drummer and Kathleen McCaffrey, contributing to a collaborative environment that fosters innovation and discovery in medical research.
Conclusion
Pantelis Poumbourios is a prominent inventor whose work in hepatitis C research has led to significant advancements in vaccine development and immune response stimulation. His contributions continue to shape the future of medical research and public health.